Research Groups and R&D Platforms: Biomedicine
Research Group:
Synthetic Glycocluster Adjuvants
Johannes Savolainen
johsav[at]utu.fi
Department of Clinical Medicine,
University of Turku
Allergy, Asthma, Biomedicine, Biomolecular chemistry, Biotechnology, Cancer, Immunology, Inflammation, Melanoma, Natural Compounds, NMR, Organic Chemistry, Synthetic Biology, Synthetic chemistry, Target discovery
Research Group:
Alpha2-Adrenoceptors as targets for drug development
Mika Scheinin
mschein[at]utu.fi
University of Turku, Turku University Hospital and CRST Oy
Clinical Research Services Turku
Ageing-related diseases, Allergy, Antibodies, Assay development, Asthma, Autoimmune diseases, Basic research, Biomarker, Biomedicine, Biopharmaceuticals, Cancer, Cardiovascular diseases, Clinical Medicine, Diabetes, Diagnostics, Disease models, Drug delivery, Drug target, Endocrinology, Imaging, In Vitro Diagnostics, In Vivo Diagnostics, Inflammation, Medicinal chemistry, Metabolic diseases, Metal disorders, Molecular diagnostics, Musculoskeletal disorders, Natural products, Neurological disorders, Obesity, Organic compounds, Personalized medicine, PET, Pharmacology, Receptor, Screening, Signaling, Skin diseases, Target discovery
Research Group:
Genetic predisposition to cancer
Johanna Schleutker
Johanna.Schleutker[at]utu.fi
Institute of Biomedicine,
University of Turku
Antibodies, Assay development, Bioinformatics, Biomarker, Biomedicine, Biotechnology, Breast cancer, Cancer, Clinical Medicine, Data mining, Diagnostics, Epidemiology, Genetics, Genomics, In Vitro Diagnostics, Inherited diseases, Machine learning, Molecular Biology, Molecular diagnostics, Next-generation sequencing, Personalized medicine, Point of care, Prostate cancer, Screening
Research Group:
Keratins as modulators of epithelial stress responses and regeneration
Diana Toivola
dtoivola[at]abo.fi
Cell Biology, Faculty of Science and Engineering,
Åbo Akademi University
Antibodies, Autoimmune diseases, Basic research, Biochemistry, Biomarker, Biomedicine, Biotechnology, Cancer, Colorectal cancer, Data mining, Diabetes, Disease models, Drug delivery, Electron microscopy, Endocrinology, Formulation, Imaging, Imaging software, Immunology, In Vivo Diagnostics, Inflammation, Metabolic diseases, Molecular Biology, Molecular Cell Biology, Nanoparticles, Obesity, Pathology, PET, Physiology, Proteomics, Receptor, Screening, Signaling, Super-resolution imaging, Target discovery, Ultrasound imaging
Research Group:
Cancer Cell Signaling
Jukka Westermarck
jukwes[at]utu.fi
Turku Bioscience Centre and Institute of Biomedicine,
University of Turku
Assay development, Basic research, Biochemistry, Biomarker, Biomedicine, Breast cancer, Cancer, Colorectal cancer, Data mining, Diagnostics, Disease models, Drug delivery, Genomics, Lung cancer, Molecular Biology, Molecular Cell Biology, Nanoparticles, Next-generation sequencing, Pathology, Personalized medicine, Prostate cancer, Proteomics, Receptor, Screening, Signaling, Squamous cell carcinoma, Systems Biology, Target discovery, X-ray crystallography
Research Group:
Radiopharmaceuticals for positron emission tomography (PET) imaging
Xiang-Guo Li
xiali[at]utu.fi
Turku PET Centre,
University of Turku
Antibodies, Assay development, Biomedicine, Cancer, Cardiovascular diseases, Clinical Chemistry, Drug delivery, Drug solubility, Drug stability, Formulation, Imaging, In Vivo Diagnostics, Infection, Inflammation, Medicinal chemistry, Metabolic diseases, Molecular diagnostics, Nanoparticles, Nucleic acids, Organic Chemistry, Organic compounds, Personalized medicine, PET, Pharmacy, Physico-chemical properties, Preclinical development, Synthetic chemistry
